BUY $PYXS (PYXS.O) [StockDilution] @ 20:21:41Z
September 29, 2026 at 8:21 PM
BUY $PYXS (PYXS.O) [StockDilution] @ 20:21:41Z
renounce ywib vuqt rlyc xtke wjrz pehq lgwo iqfk jdlu yksh gajt rhmf dnge wfbs avdq lscm nxak jmzb vpnh gboc xivf dcuz pyxs azto irpm noeu ywib°yxbi uvzt rpcy txoe wizr epuq lyow qitk jrul kyeh gwtj hrqf dleg fwks ajqd slhm ngka mjfb vdhn bgsc xafv cdmz pnsx zabo ivmp oncu yxbi° #vss365 wzvt uvqw tu
September 27, 2026 at 8:34 PM
renounce ywib vuqt rlyc xtke wjrz pehq lgwo iqfk jdlu yksh gajt rhmf dnge wfbs avdq lscm nxak jmzb vpnh gboc xivf dcuz pyxs azto irpm noeu ywib°yxbi uvzt rpcy txoe wizr epuq lyow qitk jrul kyeh gwtj hrqf dleg fwks ajqd slhm ngka mjfb vdhn bgsc xafv cdmz pnsx zabo ivmp oncu yxbi° #vss365 wzvt uvqw tu
#PYXS Pyxis Oncology Announces Proposed Public Offering
https://www.stocktitan.net/news/PYXS/pyxis-oncology-announces-proposed-public-8zz3bye6w3jh.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PYXS/pyxis-oncology-announces-proposed-public-8zz3bye6w3jh.html?utm_source=stocktitan-bluesky&utm_medium=social
Pyxis Oncology Announces Proposed Public Offering
Pyxis Oncology (Nasdaq: PYXS) has commenced a proposed public offering of common stock or pre-funded warrants, each accompanied by a common warrant. Each accompanying common warrant covers one share. Pyxis intends to use net proceeds to advance MICVO, including Headliner, its planned Phase 3 trial in second-line and beyond recurrent/metastatic head and neck squamous cell carcinoma.Common warrants become exercisable only after stockholder approval of an authorized-share increase and the amendment's effectiveness. They expire at the earlier of the fifth anniversary of that effective date or 30 calendar days after the later of that date and public disclosure of overall survival data from MICVO's ongoing Phase 1 monotherapy study. Pyxis expects those data in the first half of 2027. The proposed offering is subject to market and other conditions; completion, size and terms remain uncertain.
www.stocktitan.net
September 29, 2026 at 8:25 PM
#PYXS Pyxis Oncology Announces Proposed Public Offering
https://www.stocktitan.net/news/PYXS/pyxis-oncology-announces-proposed-public-8zz3bye6w3jh.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PYXS/pyxis-oncology-announces-proposed-public-8zz3bye6w3jh.html?utm_source=stocktitan-bluesky&utm_medium=social
Your Daily Dracula – Jetpack Dracula Tripl3 Thr3at (2018)
www.youtube.com/watch?v=pyxs...
www.youtube.com/watch?v=pyxs...
Jetpack Dracula 3 (Animation)
YouTube video by Corrupted Animation
www.youtube.com
July 30, 2026 at 7:55 AM
Your Daily Dracula – Jetpack Dracula Tripl3 Thr3at (2018)
www.youtube.com/watch?v=pyxs...
www.youtube.com/watch?v=pyxs...
the river pyxs
October 28, 2025 at 11:31 PM
the river pyxs
#PYXS Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
https://www.stocktitan.net/news/PYXS/pyxis-oncology-announces-pricing-of-up-to-282-6-million-public-7cykzcanfy04.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PYXS/pyxis-oncology-announces-pricing-of-up-to-282-6-million-public-7cykzcanfy04.html?utm_source=stocktitan-bluesky&utm_medium=social
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 30, 2026 at 5:11 AM
#PYXS Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
https://www.stocktitan.net/news/PYXS/pyxis-oncology-announces-pricing-of-up-to-282-6-million-public-7cykzcanfy04.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PYXS/pyxis-oncology-announces-pricing-of-up-to-282-6-million-public-7cykzcanfy04.html?utm_source=stocktitan-bluesky&utm_medium=social
$RFL: Phase 3 Trappsol Cyclo slowed NPC disease by 64% vs. placebo, 71% with add-on therapy. NDA filing planned Q4 2026. Safety consistent. $ERNA $SGMT $SLXN $CNTB $PYXS $NIVF $VBIO $KLRS $NRSN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Pre-Market Updates 09/30/26
export-download.canva.com
September 30, 2026 at 12:40 PM
$RFL: Phase 3 Trappsol Cyclo slowed NPC disease by 64% vs. placebo, 71% with add-on therapy. NDA filing planned Q4 2026. Safety consistent. $ERNA $SGMT $SLXN $CNTB $PYXS $NIVF $VBIO $KLRS $NRSN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
They showed attendees this video produced by the county party about the caucus.
This line stood out to me:
"Delegates spend 40-plus hours researching, meet face-to-face with candidates, and debate their merits, unlike a quick ballot swipe."
www.youtube.com/watch?v=pyxS...
This line stood out to me:
"Delegates spend 40-plus hours researching, meet face-to-face with candidates, and debate their merits, unlike a quick ballot swipe."
www.youtube.com/watch?v=pyxS...
What is Caucus?
YouTube video by Salt Lake County Republican Party
www.youtube.com
February 21, 2026 at 6:33 PM
They showed attendees this video produced by the county party about the caucus.
This line stood out to me:
"Delegates spend 40-plus hours researching, meet face-to-face with candidates, and debate their merits, unlike a quick ballot swipe."
www.youtube.com/watch?v=pyxS...
This line stood out to me:
"Delegates spend 40-plus hours researching, meet face-to-face with candidates, and debate their merits, unlike a quick ballot swipe."
www.youtube.com/watch?v=pyxS...
AHHHHH! Sigue con Rocky II y III !!! Tu vieja abandona el living hoy porque yo no! Encima en la II es donde está la escena que protagonizó en la vida real Locomotora Castro que fué una locura!! Contra todo pronóstico el chabón da vuelta la pelea. Realmente épico:
www.youtube.com/watch?v=PYxS...
www.youtube.com/watch?v=PYxS...
May 29, 2025 at 3:28 AM
AHHHHH! Sigue con Rocky II y III !!! Tu vieja abandona el living hoy porque yo no! Encima en la II es donde está la escena que protagonizó en la vida real Locomotora Castro que fué una locura!! Contra todo pronóstico el chabón da vuelta la pelea. Realmente épico:
www.youtube.com/watch?v=PYxS...
www.youtube.com/watch?v=PYxS...
Wells Fargo Raises Pyxis Oncology Price Target to $19 Following MICVO Data
Wells Fargo increased its price target for Pyxis Oncology (PYXS) from $12.00 to $19.00 while maintain…
Read more: https://embers.news/article/wells-fargo-raises-pyxis-oncology-price-target-to-19-following-micvo-data-73248
Wells Fargo increased its price target for Pyxis Oncology (PYXS) from $12.00 to $19.00 while maintain…
Read more: https://embers.news/article/wells-fargo-raises-pyxis-oncology-price-target-to-19-following-micvo-data-73248
Wells Fargo Raises Pyxis Oncology Price Target to $19 Following MICVO Data
Wells Fargo increased its price target for Pyxis Oncology (PYXS) from $12.00 to $19.00 while maintaining an Overweight rating. This revision follows clinical data for the company's MICVO treatment. The change reflects analyst confidence in the drug's performance in head and neck cancer treatment.
embers.news
September 25, 2026 at 11:10 AM
Wells Fargo Raises Pyxis Oncology Price Target to $19 Following MICVO Data
Wells Fargo increased its price target for Pyxis Oncology (PYXS) from $12.00 to $19.00 while maintain…
Read more: https://embers.news/article/wells-fargo-raises-pyxis-oncology-price-target-to-19-following-micvo-data-73248
Wells Fargo increased its price target for Pyxis Oncology (PYXS) from $12.00 to $19.00 while maintain…
Read more: https://embers.news/article/wells-fargo-raises-pyxis-oncology-price-target-to-19-following-micvo-data-73248
This concert is great listening, if you are on a deadline Pogues with Joe Strummer in 1991
music.youtube.com/watch?v=pYxs...
music.youtube.com/watch?v=pYxs...
Young Ned of the Hill (with Joe Strummer) (Live)
YouTube video by The Pogues - Topic
music.youtube.com
December 5, 2024 at 3:23 AM
This concert is great listening, if you are on a deadline Pogues with Joe Strummer in 1991
music.youtube.com/watch?v=pYxs...
music.youtube.com/watch?v=pYxs...
$PYXS files 8-K
Pyxis Oncology Reports Strong MICVO Clinical Progress, Extends Cash Runway, and Appoints New Interim CEO...
Full: https://wiseek.ai/ticker/pyxs/pyxis-oncology-reports-strong-micvo-clinical-progress-extends-cash-runway-and-appoints-new-interim-ceo-000119312526118525/
Pyxis Oncology Reports Strong MICVO Clinical Progress, Extends Cash Runway, and Appoints New Interim CEO...
Full: https://wiseek.ai/ticker/pyxs/pyxis-oncology-reports-strong-micvo-clinical-progress-extends-cash-runway-and-appoints-new-interim-ceo-000119312526118525/
March 23, 2026 at 11:19 AM
$PYXS files 8-K
Pyxis Oncology Reports Strong MICVO Clinical Progress, Extends Cash Runway, and Appoints New Interim CEO...
Full: https://wiseek.ai/ticker/pyxs/pyxis-oncology-reports-strong-micvo-clinical-progress-extends-cash-runway-and-appoints-new-interim-ceo-000119312526118525/
Pyxis Oncology Reports Strong MICVO Clinical Progress, Extends Cash Runway, and Appoints New Interim CEO...
Full: https://wiseek.ai/ticker/pyxs/pyxis-oncology-reports-strong-micvo-clinical-progress-extends-cash-runway-and-appoints-new-interim-ceo-000119312526118525/
Just In: ( NASDAQ: #PYXS ) Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201
#StockMarket #News
#StockMarket #News
November 11, 2024 at 5:20 PM
Trading Resumed for $PYXS Pyxis Oncology, Inc. CS | at 12:58:03 ET on NASDAQ | 2026-08-11
August 11, 2026 at 5:03 PM
Trading Resumed for $PYXS Pyxis Oncology, Inc. CS | at 12:58:03 ET on NASDAQ | 2026-08-11
💫 MY PYXIS MY PYXS IT'S YOUR DAY TODAYYYY!!!!! 💫
HAPPY PATCH AND COSMIC EOUGHHHH
(I will keep trying to work on his first fic eouuuu)
#PyxisLore | #FeoSulShots
HAPPY PATCH AND COSMIC EOUGHHHH
(I will keep trying to work on his first fic eouuuu)
#PyxisLore | #FeoSulShots
June 2, 2026 at 9:40 AM
💫 MY PYXIS MY PYXS IT'S YOUR DAY TODAYYYY!!!!! 💫
HAPPY PATCH AND COSMIC EOUGHHHH
(I will keep trying to work on his first fic eouuuu)
#PyxisLore | #FeoSulShots
HAPPY PATCH AND COSMIC EOUGHHHH
(I will keep trying to work on his first fic eouuuu)
#PyxisLore | #FeoSulShots
$ENVB received U.S. Patent No. 12,195,439 for its EVM401 Series, covering non-hallucinogenic mescaline derivatives that modulate key brain receptors
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/en...
$IPA $INGN $PYXS $VERO $PSTV $SINT
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/en...
$IPA $INGN $PYXS $VERO $PSTV $SINT
February 26, 2025 at 1:29 PM
$ENVB received U.S. Patent No. 12,195,439 for its EVM401 Series, covering non-hallucinogenic mescaline derivatives that modulate key brain receptors
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/en...
$IPA $INGN $PYXS $VERO $PSTV $SINT
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/en...
$IPA $INGN $PYXS $VERO $PSTV $SINT
After-hours bump for Pyxis Oncology $PYXS on early clinical data for ADC targeting extra-domain B of fibronectin: 50% ORR among six head/neck cancer pts, 26% ORR across tumor types (n=31). Starting combo study w/Keytruda next quarter. ir.pyxisoncology.com/news-release...
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data | Pyxis Oncology
— PYX-201 achieved a confirmed 50% ORR by RECIST 1.1 including one Complete Response and 100% Disease Control Rate in six heavily pretreated HNSCC patients, supporting differentiated mono and front-li...
ir.pyxisoncology.com
November 20, 2024 at 9:23 PM
After-hours bump for Pyxis Oncology $PYXS on early clinical data for ADC targeting extra-domain B of fibronectin: 50% ORR among six head/neck cancer pts, 26% ORR across tumor types (n=31). Starting combo study w/Keytruda next quarter. ir.pyxisoncology.com/news-release...
Hello Welcome to my BlueSky account! I go by the name ImPyxs or Pyxs
Useful links! : 📺
www.youtube.com/@ImPyxlites/...
roblox.com/users/112457...
Hopefully, you enjoy my videos and posts! 🤞
Have a good day!
Bye! 👋
Useful links! : 📺
www.youtube.com/@ImPyxlites/...
roblox.com/users/112457...
Hopefully, you enjoy my videos and posts! 🤞
Have a good day!
Bye! 👋
November 4, 2023 at 5:52 PM
Hello Welcome to my BlueSky account! I go by the name ImPyxs or Pyxs
Useful links! : 📺
www.youtube.com/@ImPyxlites/...
roblox.com/users/112457...
Hopefully, you enjoy my videos and posts! 🤞
Have a good day!
Bye! 👋
Useful links! : 📺
www.youtube.com/@ImPyxlites/...
roblox.com/users/112457...
Hopefully, you enjoy my videos and posts! 🤞
Have a good day!
Bye! 👋
🎯#TopUnusual Report-Part 2
🎯Verified Nov 21 Data
⚠️These 47of130 Verified & Represent Top Bullish Unusual Options Stocks:
$GOLD $ROST $TDOC $BABA $CMG $ALDX $GT $URBN $KD $PYXS $VSAT $HIMS $HBI $WBA $CELH $FSLY $TER $SNDX $PRCH $ODV $ENB $NVTS $ET
t.co/tTJHQoS4sx
🎯Verified Nov 21 Data
⚠️These 47of130 Verified & Represent Top Bullish Unusual Options Stocks:
$GOLD $ROST $TDOC $BABA $CMG $ALDX $GT $URBN $KD $PYXS $VSAT $HIMS $HBI $WBA $CELH $FSLY $TER $SNDX $PRCH $ODV $ENB $NVTS $ET
t.co/tTJHQoS4sx
November 24, 2024 at 7:02 AM
🎯#TopUnusual Report-Part 2
🎯Verified Nov 21 Data
⚠️These 47of130 Verified & Represent Top Bullish Unusual Options Stocks:
$GOLD $ROST $TDOC $BABA $CMG $ALDX $GT $URBN $KD $PYXS $VSAT $HIMS $HBI $WBA $CELH $FSLY $TER $SNDX $PRCH $ODV $ENB $NVTS $ET
t.co/tTJHQoS4sx
🎯Verified Nov 21 Data
⚠️These 47of130 Verified & Represent Top Bullish Unusual Options Stocks:
$GOLD $ROST $TDOC $BABA $CMG $ALDX $GT $URBN $KD $PYXS $VSAT $HIMS $HBI $WBA $CELH $FSLY $TER $SNDX $PRCH $ODV $ENB $NVTS $ET
t.co/tTJHQoS4sx
FUWAMOCO is right. Why ISN'T there a statue of Spider-Man in NYC? I mean he IS that city's major hero, right?
@mayor.nyc.gov Sir, I know there's other major issues going on but surely down the road we can have a Spider-Man statue in Queens, right?
www.youtube.com/watch?v=Pyxs...
@mayor.nyc.gov Sir, I know there's other major issues going on but surely down the road we can have a Spider-Man statue in Queens, right?
www.youtube.com/watch?v=Pyxs...
"Spiderman protects Gotham City" - Fuwawa, 2026 [Hololive/FuwaMoco]
YouTube video by Yabaii Ch.
www.youtube.com
September 3, 2026 at 1:03 AM
FUWAMOCO is right. Why ISN'T there a statue of Spider-Man in NYC? I mean he IS that city's major hero, right?
@mayor.nyc.gov Sir, I know there's other major issues going on but surely down the road we can have a Spider-Man statue in Queens, right?
www.youtube.com/watch?v=Pyxs...
@mayor.nyc.gov Sir, I know there's other major issues going on but surely down the road we can have a Spider-Man statue in Queens, right?
www.youtube.com/watch?v=Pyxs...
BUY $PYXS (PYXS.O) [PharmaStudy] @ 11:00:07Z
September 9, 2026 at 11:00 AM
BUY $PYXS (PYXS.O) [PharmaStudy] @ 11:00:07Z
🚨 $PYXS
On September 9, 2026, Pyxis Oncology, Inc. provided a corporate update and issued a press release announcing updated data from its ongoing global Phase 1 monotherapy study of micvotabart pelidotin (MICVO) in patients with second-line and beyond recurrent/metastatic head and neck squamous ...
On September 9, 2026, Pyxis Oncology, Inc. provided a corporate update and issued a press release announcing updated data from its ongoing global Phase 1 monotherapy study of micvotabart pelidotin (MICVO) in patients with second-line and beyond recurrent/metastatic head and neck squamous ...
SEC Filing: PYXS
Click to view the official SEC document.
www.sec.gov
September 9, 2026 at 11:35 AM
🚨 $PYXS
On September 9, 2026, Pyxis Oncology, Inc. provided a corporate update and issued a press release announcing updated data from its ongoing global Phase 1 monotherapy study of micvotabart pelidotin (MICVO) in patients with second-line and beyond recurrent/metastatic head and neck squamous ...
On September 9, 2026, Pyxis Oncology, Inc. provided a corporate update and issued a press release announcing updated data from its ongoing global Phase 1 monotherapy study of micvotabart pelidotin (MICVO) in patients with second-line and beyond recurrent/metastatic head and neck squamous ...
#$PYXS fell 13% after MICVO’s confirmed ORR slipped from 46% to 36%. Solid vs history, but neuropathy, a mid-2027 Phase 3 and cash weighed on shares. notreload.xyz/xy/micvo-res...
MICVO’s Response Rate Slipped — and So Did PYXS
Confirmed responses fell from 46% (n=13) to 36% (12/33). Data beat old 2L chemo rates, yet safety, distant catalysts and financing overhang hit the stock.
notreload.xyz
September 9, 2026 at 1:07 PM
#$PYXS fell 13% after MICVO’s confirmed ORR slipped from 46% to 36%. Solid vs history, but neuropathy, a mid-2027 Phase 3 and cash weighed on shares. notreload.xyz/xy/micvo-res...
🚨 $PYXS
The Company issued a press release in connection with the announcement of Mr. Civik’s appointment as Chief Executive Officer, a copy of which is furnished herewith as Exhibit 99.1. All of the information included in this Item 7.01 and the accompanying exhibit is being furnished and shall ...
The Company issued a press release in connection with the announcement of Mr. Civik’s appointment as Chief Executive Officer, a copy of which is furnished herewith as Exhibit 99.1. All of the information included in this Item 7.01 and the accompanying exhibit is being furnished and shall ...
SEC Filing: PYXS
Click to view the official SEC document.
www.sec.gov
September 8, 2026 at 11:40 AM
🚨 $PYXS
The Company issued a press release in connection with the announcement of Mr. Civik’s appointment as Chief Executive Officer, a copy of which is furnished herewith as Exhibit 99.1. All of the information included in this Item 7.01 and the accompanying exhibit is being furnished and shall ...
The Company issued a press release in connection with the announcement of Mr. Civik’s appointment as Chief Executive Officer, a copy of which is furnished herewith as Exhibit 99.1. All of the information included in this Item 7.01 and the accompanying exhibit is being furnished and shall ...